DK2479174T3 - 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf - Google Patents
6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser derafInfo
- Publication number
- DK2479174T3 DK2479174T3 DK10814867.7T DK10814867T DK2479174T3 DK 2479174 T3 DK2479174 T3 DK 2479174T3 DK 10814867 T DK10814867 T DK 10814867T DK 2479174 T3 DK2479174 T3 DK 2479174T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyanquinoline
- aminoquinazoline
- procedures
- derivatives
- pharmaceutical applications
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- XFGPXURFKAUHQR-UHFFFAOYSA-N quinazolin-6-amine Chemical compound N1=CN=CC2=CC(N)=CC=C21 XFGPXURFKAUHQR-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65128—Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101958233A CN102020639A (zh) | 2009-09-14 | 2009-09-14 | 6-氨基喹唑啉或3-氰基喹啉类衍生物、其制备方法及其在医药上的应用 |
| PCT/CN2010/001293 WO2011029265A1 (zh) | 2009-09-14 | 2010-08-26 | 6-氨基喹唑啉或3-氰基喹啉类衍生物、其制备方法及其在医药上的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2479174T3 true DK2479174T3 (da) | 2017-11-27 |
Family
ID=43731939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10814867.7T DK2479174T3 (da) | 2009-09-14 | 2010-08-26 | 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8901140B2 (da) |
| EP (1) | EP2479174B1 (da) |
| JP (1) | JP5684811B2 (da) |
| KR (1) | KR101738191B1 (da) |
| CN (2) | CN102020639A (da) |
| AU (1) | AU2010292790B2 (da) |
| BR (1) | BR112012005760A2 (da) |
| CA (1) | CA2774099C (da) |
| DK (1) | DK2479174T3 (da) |
| ES (1) | ES2647829T3 (da) |
| HK (1) | HK1163081A1 (da) |
| HR (1) | HRP20171748T1 (da) |
| HU (1) | HUE035873T2 (da) |
| LT (1) | LT2479174T (da) |
| MX (1) | MX2012002875A (da) |
| NO (1) | NO2479174T3 (da) |
| PL (1) | PL2479174T3 (da) |
| PT (1) | PT2479174T (da) |
| RU (1) | RU2536102C2 (da) |
| SI (1) | SI2479174T1 (da) |
| WO (1) | WO2011029265A1 (da) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102020639A (zh) | 2009-09-14 | 2011-04-20 | 上海恒瑞医药有限公司 | 6-氨基喹唑啉或3-氰基喹啉类衍生物、其制备方法及其在医药上的应用 |
| CN102675287A (zh) * | 2011-03-11 | 2012-09-19 | 江苏恒瑞医药股份有限公司 | (e)-n-[4-[[3-氯-4-(2-吡啶基甲氧基)苯基]氨基]-3-氰基-7-乙氧基-6-喹啉基]-3-[(2r)-1-甲基吡咯烷-2-基]丙-2-烯酰胺的可药用的盐、其制备方法及其在医药上的应用 |
| CN103717590B (zh) * | 2011-05-17 | 2016-05-11 | 江苏康缘药业股份有限公司 | 喹唑啉-7-醚化合物及使用方法 |
| WO2013013640A1 (zh) * | 2011-07-27 | 2013-01-31 | 上海医药集团股份有限公司 | 喹唑啉衍生物、其制备方法、中间体、组合物及其应用 |
| WO2013131424A1 (zh) * | 2012-03-09 | 2013-09-12 | 上海恒瑞医药有限公司 | 4-喹唑啉胺类衍生物及其用途 |
| CN103539783A (zh) * | 2012-07-12 | 2014-01-29 | 江苏恒瑞医药股份有限公司 | 一种酪氨酸激酶抑制剂的二马来酸盐的i型结晶及制备方法 |
| CN103588755B (zh) * | 2012-08-17 | 2016-06-22 | 正大天晴药业集团股份有限公司 | Neratinib的制备方法 |
| CN103965120B (zh) * | 2013-01-25 | 2016-08-17 | 上海医药集团股份有限公司 | 喹啉及喹唑啉衍生物、制备方法、中间体、组合物及应用 |
| TWI609012B (zh) | 2013-04-28 | 2017-12-21 | 廣東東陽光藥業有限公司 | 氨基喹唑啉類衍生物及其鹽和使用方法 |
| JP6342001B2 (ja) * | 2013-12-12 | 2018-06-13 | 天津和美奥康医薬科技有限公司 | キナゾリン誘導体 |
| WO2015154725A1 (zh) * | 2014-04-11 | 2015-10-15 | 四川海思科制药有限公司 | 喹唑啉衍生物及其制备方法和在医药上的应用 |
| CA3008701A1 (en) | 2016-01-27 | 2017-08-03 | Jiangsu Hengrui Medicine Co., Ltd. | Method for preparing pharmaceutical composition comprising quinoline derivative or salt thereof |
| AU2017212452B2 (en) * | 2016-01-27 | 2022-04-14 | Jiangsu Hengrui Medicine Co., Ltd. | Pharmaceutical composition comprising quinoline derivative or salt thereof |
| WO2017129094A1 (zh) * | 2016-01-28 | 2017-08-03 | 江苏恒瑞医药股份有限公司 | 一种egfr/her2受体酪氨酸激酶抑制剂在制备治疗her2突变癌症药物中的用途 |
| CN105777604A (zh) * | 2016-04-14 | 2016-07-20 | 上海凯宝药业股份有限公司 | 一种n-甲基-反式-4-羟基-l-脯氨酸晶体化合物及其制备方法 |
| US10793548B2 (en) * | 2016-04-28 | 2020-10-06 | Jiangsu Hengrui Medicine Co., Ltd. | Method for preparing tyrosine kinase inhibitor and derivative thereof |
| CN106008471B (zh) * | 2016-05-25 | 2019-09-03 | 江苏医诺万细胞诊疗有限公司 | 一种喹唑啉类化合物的合成方法 |
| CN108289885B (zh) * | 2016-09-23 | 2020-10-20 | 江苏恒瑞医药股份有限公司 | 酪氨酸激酶抑制剂在制备治疗癌症药物中的用途 |
| US10870627B2 (en) | 2016-09-23 | 2020-12-22 | Shanghai Pharmaceuticals Holding Co., Ltd. | Salt of quinazoline derivative, preparation method therefor and application thereof |
| CN106565692A (zh) * | 2016-11-03 | 2017-04-19 | 常茂生物化学工程股份有限公司 | 一种阿法替尼合成工艺的改进方法 |
| WO2018133838A1 (zh) * | 2017-01-22 | 2018-07-26 | 江苏恒瑞医药股份有限公司 | Egfr/her2抑制剂联合嘧啶类抗代谢药物的用途 |
| CN109963846A (zh) * | 2017-08-07 | 2019-07-02 | 江苏恒瑞医药股份有限公司 | 一种酪氨酸激酶抑制剂的二马来酸盐的晶型及其制备方法 |
| JP7333313B2 (ja) * | 2017-09-01 | 2023-08-24 | シャンハイ ファーマシューティカルズ ホールディング カンパニー，リミティド | 窒素含有複素環化合物、製造方法、中間体、組成物および使用 |
| CA3079277A1 (en) * | 2017-10-18 | 2019-04-25 | Jiangsu Hengrui Medicine Co., Ltd. | Preparation method for tyrosine kinase inhibitor and intermediate thereof |
| UA125706C2 (uk) * | 2017-10-24 | 2022-05-18 | Цзянсу Хенжуй Медісін Ко., Лтд. | Фармацевтична композиція, яка містить похідну хіноліну |
| WO2019080889A1 (zh) * | 2017-10-26 | 2019-05-02 | 江苏恒瑞医药股份有限公司 | 抗csf-1r抗体、其抗原结合片段及其医药用途 |
| CN108314639B (zh) * | 2018-05-09 | 2019-04-30 | 山东铂源药业有限公司 | 化合物（e）-3-（1-甲基吡咯烷-2-基）-丙烯酸盐酸盐及合成方法 |
| CN110840892A (zh) * | 2018-08-21 | 2020-02-28 | 江苏恒瑞医药股份有限公司 | 酪氨酸激酶抑制剂与cdk4/6抑制剂联合在制备预防或治疗肿瘤疾病的药物中的用途 |
| CN110960529A (zh) * | 2018-09-30 | 2020-04-07 | 江苏恒瑞医药股份有限公司 | 一种降低了毒性杂质含量的酪氨酸激酶抑制剂的原料药 |
| WO2020083188A1 (zh) | 2018-10-22 | 2020-04-30 | 江苏恒瑞医药股份有限公司 | 一种酪氨酸激酶抑制剂的一马来酸盐的晶型及其制备方法 |
| SG11202106635WA (en) | 2018-12-21 | 2021-07-29 | Daiichi Sankyo Co Ltd | Combination of antibody-drug conjugate and kinase inhibitor |
| CN112279838B (zh) * | 2020-10-29 | 2021-07-13 | 苏州富士莱医药股份有限公司 | 一种吡咯替尼的制备方法 |
| CN112694439B (zh) * | 2020-12-31 | 2022-08-30 | 河南省医药科学研究院 | 苯基丙烯酰胺基喹啉类衍生物及其制备方法和用途 |
| CN112759583B (zh) * | 2020-12-31 | 2022-10-11 | 河南省医药科学研究院 | 包含呋喃基的喹啉类衍生物及其制备方法和用途 |
| CN112625025B (zh) * | 2020-12-31 | 2022-03-29 | 河南省医药科学研究院 | 吡啶基取代的喹啉类衍生物及其制备方法和用途 |
| US20240246934A1 (en) | 2021-03-19 | 2024-07-25 | Beijing Scitech-Mq Pharmaceuticals Limited | Quinazoline-based compound, composition, and application of quinazoline-based compound |
| CN118201613A (zh) * | 2021-10-14 | 2024-06-14 | 江苏恒瑞医药股份有限公司 | 抗her2抗体药物偶联物和酪氨酸激酶抑制剂联合在制备治疗肿瘤的药物中的用途 |
| WO2024187321A1 (zh) * | 2023-03-10 | 2024-09-19 | 甫康（上海）健康科技有限责任公司 | 含有egfr抑制剂的药物组合物及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73073C2 (uk) | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
| PT1117659E (pt) | 1998-09-29 | 2004-04-30 | Wyeth Corp | Cianoquinolinas substituidas como inibidores de tirosina-quinases de proteinas |
| JP4939716B2 (ja) * | 2000-04-08 | 2012-05-30 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 二環式複素環化合物、これらの化合物を含む医薬組成物、それらの使用及びそれらの調製方法 |
| US7019012B2 (en) | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
| US20040044014A1 (en) * | 2002-04-19 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| DE10217689A1 (de) | 2002-04-19 | 2003-11-13 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
| DE10307165A1 (de) * | 2003-02-20 | 2004-09-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
| US7399865B2 (en) | 2003-09-15 | 2008-07-15 | Wyeth | Protein tyrosine kinase enzyme inhibitors |
| KR100832594B1 (ko) | 2005-11-08 | 2008-05-27 | 한미약품 주식회사 | 다중저해제로서의 퀴나졸린 유도체 및 이의 제조방법 |
| CN101824029A (zh) * | 2009-03-05 | 2010-09-08 | 厦门艾德生物医药科技有限公司 | 酪氨酸激酶不可逆抑制剂、其药物组合物及其用途 |
| CN102020639A (zh) | 2009-09-14 | 2011-04-20 | 上海恒瑞医药有限公司 | 6-氨基喹唑啉或3-氰基喹啉类衍生物、其制备方法及其在医药上的应用 |
-
2009
- 2009-09-14 CN CN2009101958233A patent/CN102020639A/zh active Pending
-
2010
- 2010-08-26 AU AU2010292790A patent/AU2010292790B2/en active Active
- 2010-08-26 PT PT108148677T patent/PT2479174T/pt unknown
- 2010-08-26 CA CA2774099A patent/CA2774099C/en active Active
- 2010-08-26 CN CN201080030048.7A patent/CN102471312B/zh active Active
- 2010-08-26 DK DK10814867.7T patent/DK2479174T3/da active
- 2010-08-26 NO NO10814867A patent/NO2479174T3/no unknown
- 2010-08-26 RU RU2012110882/04A patent/RU2536102C2/ru active
- 2010-08-26 KR KR1020127009554A patent/KR101738191B1/ko active IP Right Grant
- 2010-08-26 WO PCT/CN2010/001293 patent/WO2011029265A1/zh active Application Filing
- 2010-08-26 SI SI201031574T patent/SI2479174T1/sl unknown
- 2010-08-26 EP EP10814867.7A patent/EP2479174B1/en active Active
- 2010-08-26 US US13/395,892 patent/US8901140B2/en active Active
- 2010-08-26 ES ES10814867.7T patent/ES2647829T3/es active Active
- 2010-08-26 BR BR112012005760A patent/BR112012005760A2/pt not_active Application Discontinuation
- 2010-08-26 HU HUE10814867A patent/HUE035873T2/en unknown
- 2010-08-26 MX MX2012002875A patent/MX2012002875A/es active IP Right Grant
- 2010-08-26 PL PL10814867T patent/PL2479174T3/pl unknown
- 2010-08-26 LT LTEP10814867.7T patent/LT2479174T/lt unknown
- 2010-08-26 JP JP2012528211A patent/JP5684811B2/ja active Active
-
2012
- 2012-04-16 HK HK12103680A patent/HK1163081A1/xx unknown
-
2014
- 2014-12-01 US US14/556,792 patent/US9358227B2/en active Active
-
2017
- 2017-11-14 HR HRP20171748TT patent/HRP20171748T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102471312A (zh) | 2012-05-23 |
| JP2013504521A (ja) | 2013-02-07 |
| CN102471312B (zh) | 2014-06-18 |
| US20150126550A1 (en) | 2015-05-07 |
| BR112012005760A2 (pt) | 2016-02-16 |
| US9358227B2 (en) | 2016-06-07 |
| MX2012002875A (es) | 2012-04-20 |
| RU2012110882A (ru) | 2013-11-10 |
| ES2647829T3 (es) | 2017-12-26 |
| KR20120081142A (ko) | 2012-07-18 |
| PT2479174T (pt) | 2017-11-20 |
| JP5684811B2 (ja) | 2015-03-18 |
| US20120165352A1 (en) | 2012-06-28 |
| HRP20171748T1 (hr) | 2017-12-29 |
| EP2479174A4 (en) | 2013-04-17 |
| EP2479174B1 (en) | 2017-10-18 |
| LT2479174T (lt) | 2017-11-27 |
| NO2479174T3 (da) | 2018-03-17 |
| PL2479174T3 (pl) | 2018-02-28 |
| AU2010292790A1 (en) | 2012-05-10 |
| EP2479174A1 (en) | 2012-07-25 |
| WO2011029265A1 (zh) | 2011-03-17 |
| HUE035873T2 (en) | 2018-05-28 |
| AU2010292790B2 (en) | 2015-03-26 |
| CN102020639A (zh) | 2011-04-20 |
| KR101738191B1 (ko) | 2017-05-19 |
| HK1163081A1 (en) | 2012-09-07 |
| RU2536102C2 (ru) | 2014-12-20 |
| CA2774099C (en) | 2017-07-04 |
| CA2774099A1 (en) | 2011-03-17 |
| US8901140B2 (en) | 2014-12-02 |
| SI2479174T1 (sl) | 2017-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2479174T3 (da) | 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf | |
| BRPI1010881A2 (pt) | derivados de triazina e suas aplicações terapêuticas. | |
| DK3292874T3 (da) | Anti-mesothelin-immunkonjugater og anvendelser deraf | |
| BRPI1010882A2 (pt) | derivados de triazina e suas aplicações terapêuticas. | |
| DK2729151T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf | |
| BR112012011902A2 (pt) | cápsula farmacêutica | |
| BRPI1012892A2 (pt) | composto, e, composição farmacêutica. | |
| BRPI0921919A2 (pt) | dispositivos médicos, aparelhos, sistemas e métodos | |
| BRPI1016117A2 (pt) | derivados de isoxazol-isoxazol e isoxasol-isotiazol. | |
| DK2490940T3 (da) | Uav-system og fremgangsmåde | |
| BRPI0920521A2 (pt) | combinação farmacêutica | |
| DK2445883T3 (da) | Heterocykliske sulfonamider, anvendelser og farmaceutiske sammensætniger deraf | |
| BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
| BRPI1011527A2 (pt) | derivados de triazina substituídos com ureidofenil e suas aplicações terapêuticas. | |
| DK2273975T3 (da) | Farmaceutiske opløsninger, fremgangsmåde til fremstilling og terapeutiske anvendelser | |
| DK2245032T3 (da) | Folater, sammensætninger og anvendelser deraf | |
| DK2432456T3 (da) | Faste farmaceutiske sammensætninger og fremgangsmåder til fremstilling deraf | |
| DK2170827T3 (da) | Indolin-2-oner og aza-indolin-2-oner | |
| BR112012002877A2 (pt) | dilatador e conjunto. | |
| DK2475649T3 (da) | Indenonderivat og farmaceutisk sammensætning omfattende samme | |
| HUE037105T2 (hu) | Eljárások és készítmények tumorok megsemmisítésére | |
| DK2437830T4 (da) | Anordning til lægemiddelleveringsindretning og lægemiddelleveringsindretning | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| DK2154966T3 (da) | Benzimidazoler og farmaceutiske sammensætninger deraf | |
| DK2805746T3 (da) | Alkylamido-forbindelser og anvendelser deraf |